Biostax Corp (BTAX)

[TASBES0101]

In the 2015 IMUN 10-K and subsequent 10-Qs the company mentioned creation of an Irish subsidiary, Airmed Biopharma to take advantage to beneficial tax policies and access to the European Union markets. Quietly, in December, 2016 the company was dissolved. I haven't been able to find where it was mentioned they would be doing this and why. Anyone have any ideas?

http://www.businessbarometer.ie/Risk-Management/Airmed-Biopharma-Limited-541012

From 10-K
In March 2015, the Company incorporated Airmed Biopharma Limited, an Irish corporation with an address in Dublin, Ireland, and Airmed Holdings Limited, an Irish company domiciled in Bermuda. The Irish companies were set up to benefit from incentives granted by the Irish government for the establishment of pharmaceutical companies (many of the world's leading pharmaceutical companies have located in Ireland), and so that the Company could take advantage of Ireland's status as a member of the European Union and the European Economic Area. An Irish limited liability company enjoys a low corporate income tax rate of 12.5%, one of the lowest in the world. The Irish-domiciled company hopes to qualify for tax incentives for Irish holding/headquartered companies and to benefit from the network of double tax treaties that reduce withholding taxes. TNI BioTech International, Ltd. will manage our international distribution, using product that is manufactured in Ireland and elsewhere.